ARCHIVES

Bevacizumab And Irinotecan May Increase Survival Of GBM

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

Elevated Baseline Glucose Levels Associated With Higher Cancer Risk

November 25, 2011

Study: Gene Assay Can Provide Valid Prognostic Information

January 31, 2014

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

Cancer Control Seeks Grant Applications In Three Interventions Areas And In Community Development

September 13, 1974

Duke’s Victor Dzau Named President of The Institute of Medicine

February 21, 2014

As For-Profits Provide Phase I Studies, NCI Seeks to Look Deeper and Learn More

April 6, 2012